Filing Flows › Adia Med (ADIA) › Q1 2026 › vs Q1 2025
Adia Med (ADIA) Q1 2026 vs Q1 2025 (year over year)
Adia Med's revenue rose $105K (+146%) from $72K in Q1 2025 to $176K in Q1 2026. The biggest changes: Sales of Biologics +$70K (—); Medical Procedures +$34K (+48%); Shipping and Delivery +$2K (—).
Adia Med, Q1 2026: revenue $176K (+146% year over year), operating margin -86.2%, net loss $163K, operating cash flow −$55K. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Medical Procedures | $105K | $71K | $34K | +48% |
| Sales of Biologics | $70K | $0 | $70K | — |
| Shipping and Delivery | $2K | $0 | $2K | — |
| Revenue | $176K | $72K | $105K | +146% |
| Net loss | $163K | $116K | $46K | +40% |
| Costs & expenses | $339K | $188K | $151K | +80% |
| Operating costs | $328K | $182K | $146K | +80% |
| Interest & other, net | $11K | $6K | $5K | +87% |
| Cost of revenue | $109K | $58K | $51K | +88% |
| Sales & marketing | $37K | $22K | $15K | +72% |
| General & admin | $182K | $103K | $79K | +77% |
| Operating cash sources | $163K | $116K | $46K | +40% |
| Depreciation | $1K | $1K | $477 | +62% |
| Working capital & other | $106K | $84K | $22K | +26% |
| Cash used in operations | $55K | $31K | $24K | +77% |
| Net loss absorbed | $163K | $116K | $46K | +40% |
Questions
How much did Adia Med's revenue grow year over year in Q1 2026?
Adia Med's revenue rose $105K (+146%) from $72K in Q1 2025 to $176K in Q1 2026.
What drove Adia Med's revenue change in Q1 2026?
Sales of Biologics +$70K (—); Medical Procedures +$34K (+48%); Shipping and Delivery +$2K (—).